Cellectar Biosciences (CLRB) Short Interest Ratio & Short Volume $0.26 +0.01 (+5.01%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$0.27 +0.00 (+0.68%) As of 05/1/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectar Biosciences Short Interest DataCellectar Biosciences (CLRB) has a short interest of 2.26 million shares, representing 4.99% of the float (the number of shares available for trading by the public). This marks a 1.80% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.0, indicating that it would take 2.0 days of the average trading volume of 1.14 million shares to cover all short positions.Current Short Interest2,260,000 sharesPrevious Short Interest2,220,000 sharesChange Vs. Previous Month+1.80%Dollar Volume Sold Short$663,536.00Short Interest Ratio2.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares46,080,000 sharesFloat Size45,310,000 sharesShort Percent of Float4.99%Today's Trading Volume360,526 sharesAverage Trading Volume1,135,547 sharesToday's Volume Vs. Average32% Short Selling Cellectar Biosciences? Sign up to receive the latest short interest report for Cellectar Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLRB Short Interest Over TimeCLRB Days to Cover Over TimeCLRB Percentage of Float Shorted Over Time Cellectar Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20252,260,000 shares $663,536.00 +1.8%5.0%2 $0.29 3/31/20252,220,000 shares $699,966.00 -24.0%4.9%1.4 $0.32 3/15/20252,920,000 shares $921,552.00 +48.2%6.4%1.5 $0.32 2/28/20251,970,000 shares $570,315.00 -15.8%4.4%0.7 $0.29 2/15/20252,340,000 shares $680,472.00 -0.9%5.2%0.9 $0.29 1/31/20252,360,000 shares $593,304.00 -25.1%5.3%0.9 $0.25 1/15/20253,150,000 shares $781,515.00 +67.6%7.9%1.3 $0.25 12/31/20241,880,000 shares $562,120.00 -32.6%4.7%1 $0.30 12/15/20242,790,000 shares $725,400.00 +114.6%7.0%1.8 $0.26 11/30/20241,300,000 shares $2.00 million +12.1%3.3%3.9 $1.54 Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,160,000 shares $2.16 million -37.0%2.9%3.6 $1.86 10/31/20241,840,000 shares $3.75 million -6.1%4.7%7.5 $2.04 10/15/20241,960,000 shares $4.00 million -10.9%5.7%6.2 $2.04 9/30/20242,200,000 shares $4.71 million +35.8%6.3%4.6 $2.14 9/15/20241,620,000 shares $3.45 million -37.0%4.7%3 $2.13 8/31/20242,570,000 shares $5.65 million +0.8%7.4%4.6 $2.20 8/15/20242,550,000 shares $5.18 million -10.2%7.4%4.3 $2.03 7/31/20242,840,000 shares $6.11 million +27.9%8.2%4.5 $2.15 7/15/20242,220,000 shares $5.68 million -2.2%6.4%3.4 $2.56 6/30/20242,270,000 shares $5.68 million -4.2%6.5%3.8 $2.50 6/15/20242,370,000 shares $7.63 million +9.2%6.8%3.5 $3.22 5/31/20242,170,000 shares $6.71 million -4.4%6.3%2.8 $3.09 5/15/20242,270,000 shares $7.63 million -11.0%6.5%2.4 $3.36 4/30/20242,550,000 shares $7.88 million +16.4%7.9%2.7 $3.09 4/15/20242,190,000 shares $7.27 million -13.4%7.5%2 $3.32 3/31/20242,530,000 shares $10.07 million +34.6%8.7%1.4 $3.98 3/15/20241,880,000 shares $6.54 million -6.5%16.9%1.1 $3.48 2/29/20242,010,000 shares $7.88 million -15.2%17.0%1.2 $3.92 2/15/20242,370,000 shares $8.51 million +25.4%20.1%1.6 $3.59 1/31/20241,890,000 shares $7.39 million +13.2%17.2%1.4 $3.91 1/15/20241,670,000 shares $5.86 million +208.6%15.2%1.5 $3.51 12/31/2023541,100 shares $1.50 million -9.8%4.9%0.6 $2.77 12/15/2023599,900 shares $1.59 million -11.4%5.5%3.2 $2.65 11/30/2023676,700 shares $1.67 million -15.4%6.7%3.9 $2.47 11/15/2023800,100 shares $1.58 million -7.2%6.9%1.1 $1.98 10/31/2023861,800 shares $2.09 million +3.2%9.2%1.3 $2.42 10/15/2023835,300 shares $2.16 million +25.8%8.9%1.3 $2.59 9/30/2023664,100 shares $1.75 million +37.7%7.1%1 $2.64 9/15/2023482,200 shares $1.07 million +238.4%5.2%0.8 $2.21 8/31/2023142,500 shares $252,225.00 -1.8%1.6%0.2 $1.77Elon Set to Shock the World by May 1st ? (Ad)Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX. Click here now because after June 1st, it could be too late. 8/15/2023145,100 shares $248,121.00 -9.3%1.6%5.7 $1.71 7/31/2023159,900 shares $311,805.00 +15.0%1.7%4.8 $1.95 7/15/2023139,100 shares $255,944.00 +8.9%1.5%3.7 $1.84 6/30/2023127,700 shares $249,015.00 +18.5%1.4%3.3 $1.95 6/15/2023107,800 shares $220,990.00 +29.4%1.2%2.7 $2.05 5/31/202383,300 shares $129,948.00 +2.7%0.9%2.2 $1.56 5/15/202381,100 shares $111,918.00 -7.4%0.9%1.4 $1.38 4/30/202387,600 shares $134,904.00 +25.5%1.0%1.4 $1.54 4/15/202369,800 shares $97,720.00 +47.3%0.8%1.2 $1.40 3/31/202347,400 shares $67,782.00 +4.2%0.5%0.8 $1.43 3/15/202345,500 shares $69,160.00 +237.0%0.5%0.7 $1.52 2/28/202313,500 shares $21,060.00 -49.6%0.2%0.2 $1.56 2/15/202326,800 shares $44,656.84 +8.1%0.3%0.5 $1.67 1/31/202324,800 shares $37,448.00 -40.0%0.3%0.5 $1.51 1/15/202341,300 shares $70,416.50 +50.7%0.5%0.7 $1.71 12/30/202227,400 shares $46,854.00 +144.6%0.3%0.5 $1.71 12/15/202211,200 shares $15,344.00 -9.7%0.1%0.2 $1.37 11/30/202212,400 shares $23,312.00 +53.1%0.1%0.3 $1.88 11/15/20228,100 shares $15,309.00 -16.5%0.1%0.2 $1.89 10/31/20229,700 shares $19,594.00 +61.7%0.1%0.3 $2.02 10/15/20226,000 shares $12,540.00 -1.6%0.1%0.2 $2.09 9/30/20226,100 shares $20,496.00 -28.2%0.1%0.2 $3.36 9/15/20228,500 shares $40,460.00 +6.3%0.2%0.4 $4.76 8/31/20228,000 shares $43,872.00 -64.8%0.1%0.3 $5.48 8/15/202222,700 shares $141,875.00 +59.9%0.4%0.9 $6.25 7/31/202214,200 shares $55,664.00 +647.4%0.3%0.6 $3.92 7/15/20221,900 shares $8,168.08 +111.1%N/A0.1 $4.30 6/30/20229,200 shares $3,716.80 -55.3%0.2%0.1 $0.40 6/15/202220,600 shares $7,698.22 -61.5%0.4%0.1 $0.37 5/31/202253,500 shares $21,935.00 +2.9%N/A0.3 $0.41 5/15/202252,000 shares $19,760.00 +112.2%N/A0.3 $0.38 4/30/202224,500 shares $13,107.50 -55.7%N/A0.1 $0.54 4/15/202255,300 shares $38,079.58 -74.2%N/A0.3 $0.69 3/31/2022214,700 shares $147,670.66 +70.1%N/A1.1 $0.69 3/15/2022126,200 shares $59,440.20 +10.8%N/A0.5 $0.47 2/28/2022113,900 shares $58,145.95 -43.1%N/A0.4 $0.51 2/15/2022200,100 shares $110,455.20 -14.4%N/A0.6 $0.55 1/31/2022233,800 shares $140,280.00 +283.9%N/A0.7 $0.60 1/15/202260,900 shares $42,563.01 +138.8%N/A0.2 $0.70 12/31/202125,500 shares $16,932.00 -74.6%N/A0.1 $0.66 12/15/2021100,500 shares $68,048.55 -32.7%N/A0.3 $0.68 11/30/2021149,300 shares $103,166.30 +112.1%N/A0.4 $0.69 11/15/202170,400 shares $59,368.32 -27.9%N/A0.2 $0.84 10/29/202197,700 shares $84,217.40 -38.4%N/A0.2 $0.86 10/15/2021158,700 shares $145,543.77 -85.2%N/A0.3 $0.92 9/30/20211,070,000 shares $989,750.00 +2.9%N/A1.4 $0.93 9/15/20211,040,000 shares $1.02 million -4.6%N/A1.2 $0.98 8/31/20211,090,000 shares $1.11 million -16.2%N/A1.1 $1.02 8/13/20211,300,000 shares $1.13 million -13.3%N/A1.3 $0.87 7/30/20211,500,000 shares $1.64 million -5.7%3.2%1.8 $1.09Elon Set to Shock the World by May 1st ? (Ad)Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX. Click here now because after June 1st, it could be too late. 7/15/20211,590,000 shares $1.67 million +40.7%3.4%2.1 $1.05 6/30/20211,130,000 shares $1.34 million -26.1%2.4%1.6 $1.19 6/15/20211,530,000 shares $2.00 million -12.1%3.2%2.6 $1.31 5/28/20211,740,000 shares $2.85 million +4.8%3.7%2.5 $1.64 5/14/20211,660,000 shares $2.08 million -11.7%N/A1.9 $1.25 4/30/20211,880,000 shares $2.91 million +2.2%N/A1.4 $1.55 4/15/20211,840,000 shares $2.74 million -13.2%N/A1.1 $1.49 3/31/20212,120,000 shares $3.26 million -1.4%N/A1.1 $1.54 3/15/20212,150,000 shares $4.19 million -9.3%N/A0.9 $1.95 2/26/20212,370,000 shares $4.67 million +2.6%N/A0.9 $1.97 2/12/20212,310,000 shares $5.73 million +4.1%N/A0.8 $2.48 1/29/20212,220,000 shares $3.95 million -1.3%N/A0.9 $1.78 1/15/20212,250,000 shares $4.61 million -11.1%N/A1.1 $2.05 12/31/20202,530,000 shares $5.44 million -4.2%N/A1.4 $2.15 12/15/20202,640,000 shares $5.46 million +161.4%N/A1.7 $2.07 11/30/20201,010,000 shares $1.24 million -3.8%N/A1.1 $1.23 11/15/20201,050,000 shares $1.19 million -2.8%N/A3.9 $1.13 10/30/20201,080,000 shares $1.29 million +4.9%N/A2.8 $1.19 10/15/20201,030,000 shares $1.30 million -1.0%N/A1.6 $1.26 9/30/20201,040,000 shares $1.29 million +1.0%N/A1.4 $1.24 9/15/20201,030,000 shares $1.28 million -8.0%N/A1.2 $1.24 8/31/20201,120,000 shares $1.33 million +6.7%N/A1.2 $1.19 8/14/20201,050,000 shares $1.50 million -6.3%N/A0.8 $1.43 7/31/20201,120,000 shares $1.69 million +284.2%N/A1 $1.51 7/15/2020291,500 shares $411,015.00 +213.4%N/A0.3 $1.41 6/30/202093,000 shares $120,900.00 +54.7%N/A0.1 $1.30 6/15/202060,100 shares $70,918.00 -94.1%N/A0.1 $1.18 5/29/20201,010,000 shares $1.53 million +1,681.3%N/A2 $1.51 5/15/202056,700 shares $82,215.00 +6,200.0%0.7%0.4 $1.45 CLRB Short Interest - Frequently Asked Questions What is Cellectar Biosciences' current short interest? Short interest is the volume of Cellectar Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 2,260,000 shares of CLRB short. 4.99% of Cellectar Biosciences' shares are currently sold short. Learn More on Cellectar Biosciences' current short interest. What is a good short interest ratio for Cellectar Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLRB shares currently have a short interest ratio of 2.0. Learn More on Cellectar Biosciences's short interest ratio. Which institutional investors are shorting Cellectar Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cellectar Biosciences: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Cellectar Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.99% of Cellectar Biosciences' floating shares are currently sold short. Is Cellectar Biosciences' short interest increasing or decreasing? Cellectar Biosciences saw a increase in short interest in April. As of April 15th, there was short interest totaling 2,260,000 shares, an increase of 1.8% from the previous total of 2,220,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cellectar Biosciences' float size? Cellectar Biosciences currently has issued a total of 46,080,000 shares. Some of Cellectar Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellectar Biosciences currently has a public float of 45,310,000 shares. How does Cellectar Biosciences' short interest compare to its competitors? 4.99% of Cellectar Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cellectar Biosciences: Kronos Bio, Inc. (1.71%), Precision BioSciences, Inc. (21.96%), Immix Biopharma, Inc. (1.16%), OKYO Pharma Limited (0.63%), PepGen Inc. (10.13%), Immuneering Co. (2.97%), Karyopharm Therapeutics Inc. (23.11%), PMV Pharmaceuticals, Inc. (1.91%), Avalo Therapeutics, Inc. (1.18%), Prelude Therapeutics Incorporated (8.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Cellectar Biosciences stock? Short selling CLRB is an investing strategy that aims to generate trading profit from Cellectar Biosciences as its price is falling. CLRB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cellectar Biosciences? A short squeeze for Cellectar Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLRB, which in turn drives the price of the stock up even further. How often is Cellectar Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLRB, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Kronos Bio Short Interest Precision BioSciences Short Interest Immix Biopharma Short Interest OKYO Pharma Short Interest PepGen Short Interest Immuneering Short Interest Karyopharm Therapeutics Short Interest PMV Pharmaceuticals Short Interest Avalo Therapeutics Short Interest Prelude Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLRB) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLRB Stock Free CLRB Stock Alerts